GlobalGov › Germany › Solicitation

Germany – Social work services – Abschluss von Verträgen über eine besondere Versorgung gemäß § 140a SGB V zur Digitalen Darmkrebsvorsorge mit jederzeitiger Abschlussmöglichkeit im Rahmen des sog. open house Verfahrens

Health · Germany government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

January 31, 2028
Response Due
Active
Status

Opportunity Overview

Germany – Social work services – Conclusion of contracts for special care pursuant to Section 140a of the German Social Code, Book V (SGB V) for digital colorectal cancer screening, with the option to conclude the contract at any time within the framework of the so-called open house procedure.

This is one of 1,754 active Germany Health Services opportunities most of your competitors will never see.

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyHealth
CountryGermany
CategoryHealth Services
PublishedJune 19, 2024
Procurement stageActive solicitation
Response dueJanuary 31, 2028
StatusOpen — accepting responses
TranslationTranslated from German by GlobalGov’s translation pipeline
Official sourceView original notice
Last verifiedAugust 09, 2026

Source: Tenders Electronic Daily (TED), © European Union. Notice content reused under Commission Decision 2011/833/EU; editorial content licensed CC BY 4.0. GlobalGov is not affiliated with the European Union.

Germany market overview →Browse all categories →

Related Opportunities in Germany

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Distigmin (ATC-Code nach WHO: N07AA03)
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarung nach § 130a Abs. 8 SGB V zu dem Wirkstoff Ciclosporin (S01XA18)
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Tamoxifen, ATC L02BA01
Germany – Pharmaceutical products – Open-House-Verträge 2025-5 - Aflibercept
Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Colestyramin (C10AC01).
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Naloxegol (ATC-Code nach WHO: A06AH03)
Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Tafluprost (ATC: S01EE05)
Germany – Pharmaceutical products – Open house drug discount contracts Eltrombopag, ATC B02BX05

See every Germany Health Services opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Germany Health Services intelligence report in your inbox

A personalized report on Germany Health Services opportunities, emailed in 5-10 minutes. One per month, no account needed.